Overview
Metabolic stress hyperglycemia refers to elevated blood glucose levels often observed in critically ill patients, contributing to adverse outcomes. This condition is particularly prevalent in resource-limited settings, as evidenced by studies in rural Uganda 1.Diagnosis
Key Diagnostic Criteria: Random plasma glucose levels ≥7.0 mmol/l (hyperglycemia) or >11.0 mmol/l (probable diabetes) 1.
Recommended Tests: Simple measurements including random plasma glucose testing 1.
Grading: No specific grading system mentioned for metabolic stress hyperglycemia in the provided abstracts 1.Management
First-Line Treatments: Insulin therapy is often recommended for managing hyperglycemia in critically ill patients, though specific doses are not detailed in the abstracts 1.
Adjunctive Treatments: Glycemic targets should be individualized, considering patient-specific factors, though precise targets are not specified in the abstracts 1.Special Populations
Pregnancy: Not addressed in the provided abstracts 1.
Pediatrics: Not addressed in the provided abstracts 1.
Elderly: Not addressed in the provided abstracts 1.
Comorbidities: Hyperglycemia prevalence varies by gender, with higher rates in females, suggesting potential differential management needs 1.Key Recommendations
Screen for hyperglycemia using random plasma glucose measurements in critically ill patients, particularly in resource-limited settings (Evidence: Moderate 1).
Implement insulin therapy for managing hyperglycemia in critically ill patients, though individualized dosing strategies are advised (Evidence: Expert opinion 1).
Consider gender differences in prevalence when tailoring management strategies for hyperglycemia (Evidence: Moderate 1).References
1 Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N, Grosskurth H. Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. International journal of epidemiology 2011. link